These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9861793)

  • 61. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
    Altavela JL; Jones MK; Ritter M
    J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacist-led Smoking-Cessation Services in the United States - A Multijurisdictional Legal Analysis.
    Bordner LS; Lavino J
    Innov Pharm; 2022; 13(1):. PubMed ID: 36304682
    [TBL] [Abstract][Full Text] [Related]  

  • 63. From patient centered to person centered: The pharmacist's role and value in community-integrated care transformation.
    Olson AW; Burns AL
    J Am Pharm Assoc (2003); 2023; 63(3):736-741. PubMed ID: 36934811
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacy practice acts: a decade of progress.
    Young MD; Stilling WJ; Munger MA
    Ann Pharmacother; 1999 Sep; 33(9):920-6. PubMed ID: 10492490
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessing the impact of the presence of pharmacists in a clinical department of a Lebanese hospital.
    Rabbaa-Khabbaz L; Karam L; Farhat C; Azzi R; Karam Sarkis D
    Ann Pharm Fr; 2012 Nov; 70(6):353-9. PubMed ID: 23177562
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Pharmacists' knowledge of sanitary legislation and professional regulations].
    Silva LR; Vieira EM
    Rev Saude Publica; 2004 Jun; 38(3):429-37. PubMed ID: 15243674
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacist's role in a Parkinson's disease and movement disorders clinic.
    Poon LH; Lee AJ; Chiao TB; Kang GA; Heath S; Glass GA
    Am J Health Syst Pharm; 2012 Mar; 69(6):518-20. PubMed ID: 22382484
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Pharmacist's interview with type 2 diabetes: Development of a follow-up form].
    Garcia Santos P; Bernard L; Bedhomme S; Blum S; Gravelin M; Leonce MF; McLeod ML; Roche B; Roche MC; Van Lander A; Sautou V; Vennat B
    Ann Pharm Fr; 2017 Sep; 75(5):385-397. PubMed ID: 28583318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Do community pharmacist performance evaluations capture the modern pharmacist's role? Mapping competencies assessed in Canadian community pharmacy performance evaluation templates against the General Level Framework.
    Chong IYM; Rosenthal MM; Manson KR; Houle SKD
    J Am Pharm Assoc (2003); 2018; 58(6):638-642.e2. PubMed ID: 30237009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Does hospitalization influence patients' medication adherence and community pharmacists' interventions?
    Beloin-Jubinville B; Joly-Mischlich T; Rouleau ED; Noiseux P; Blais L; Forget A; Beauchesne MF
    Ann Pharmacother; 2013 Sep; 47(9):1143-52. PubMed ID: 24259729
    [TBL] [Abstract][Full Text] [Related]  

  • 71. From pill-counting to patient care: pharmacists' standard of care in negligence law.
    Fleischer L
    Fordham Law Rev; 1999 Oct; 68(1):165-87. PubMed ID: 10848081
    [No Abstract]   [Full Text] [Related]  

  • 72. The role of the pharmacist in a geriatric nursing home: a literature review.
    Dyer CC; Oles KS; Davis SW
    Drug Intell Clin Pharm; 1984 May; 18(5):428-33. PubMed ID: 6373216
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
    Nutescu EA; Klotz RS
    Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The pharmacist's progress toward implementing pharmaceutical care.
    Trinca CE
    Am Pharm; 1995; Suppl():13-8. PubMed ID: 7677060
    [No Abstract]   [Full Text] [Related]  

  • 75. Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services.
    Kelly DV; Young S; Phillips L; Clark D
    Can Pharm J (Ott); 2014 Jul; 147(4):239-47. PubMed ID: 25360150
    [TBL] [Abstract][Full Text] [Related]  

  • 76. China's regional inequity in pharmacist's drug safety practice.
    Tang L
    Int J Equity Health; 2012 Aug; 11():38. PubMed ID: 22867000
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Continuum of Pharmacist Prescriptive Authority.
    Adams AJ; Weaver KK
    Ann Pharmacother; 2016 Sep; 50(9):778-84. PubMed ID: 27307413
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.
    Freeman PR; Goodin A; Troske S; Strahl A; Fallin A; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S28-S33. PubMed ID: 28139459
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Factors influencing pharmacists' preference for the legal classification of Rx-to-OTC switched drug products.
    Madhaven S
    J Clin Pharm Ther; 1993 Aug; 18(4):281-90. PubMed ID: 8227236
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.